Thought you might be interested that Qiagen are also presenting at the Point-of-Care Diagnostics & Global Health World Congress in September. Here is the brief regarding the presentation;
Technology Spotlight: Isothermal Amplification Detection Roberto Spricigo, OEM Manager, Point-of-Need, QIAGEN Lake Constance
"The need for a thermal cycling instrument or a skilled technician to perform a PCR assay can sometimes be prohibitive for resource-poor settings. The presentation gives an overview on isothermal amplification technologies and the new dedicated solutions provided by QIAGEN Lake Constance GmbH. Sensing nucleic acid sequences is crucial for modern biology and medicine. This sector has grown exponentially since the 1990s and it is likely to continue to increase in its importance over the next few decades."
Next to the brief is Qiagen logo and when you click on it, it goes straight to;
ESEQuant LR3 top of the page.
Which device is mix and go involved in with the Qiagen? yep, this device.
So now we have two presentation at this conference both with partners that will be talking about work they are doing with Anteo.
The other one, in case you missed it is here;
Enabling Platforms for Multiplex Diagnostics Claude Dufresne, President, SCIENION US INC, United States of America
A number of technologies have evolved that are very well suited for the creation and manufacturing of multiplex diagnostics tests. This presentation will illustrate how biological content can be used to create high quality diagnostics devices. Examples covering different platforms will include R&D and production aspects on lateral flow strips, microarrays in microtiterplates, and on custom biochips. While Lateral Flow test strips have been around for a long time, their multiplex version, based on spot arrays, is just now emerging in the next wave of low cost diagnostics. In central diagnostic labs, the use of microarrays in microtiter plates allows for a high degree of multiplexing together with a very high sample throughput. Finally, a number of companies have developed unique diagnostic format platforms. Often based on custom fabricated biosensors, electrodes or other CMOS structures need to be loaded with biological substances in a way that does not damage surface features.
Another couple of interesting presentations which sounded like it could include mix and go is this;
Fabrication and Integration of Polymer-based Sample-to-Answer Microfluidic Systems for Rapid Molecular-based Diagnostic Applications Teodor Veres, Group Leader/Adjunct Professor, National Research Council of Canada, Canada
The development of disposable microfluidic devices for rapid point-of-care applications has become central to progress in medical diagnostics and a variety of other fields. The use of these systems is attractive because they promote reduced sample consumption and analysis time without being restricted to standard laboratory settings. To this end, lab-on-a-chip (LOC) systems have mostly been shown to function in conceptual ways, yet their commercialization and widespread in clinical use has been hindered by a number of challenges, which include materials and low-cost fabrication technologies as primary concerns. We will present specific examples of designs and fabrication processes using thermoplastics polymers able to produce microfluidic systems for rapid diagnostics applications. Examples of all-thermoplastic integrated sample-to-answer centrifugal microfluidic systems for nucleic acid analysis performing less than one hour cellular lysis, polymerase chain reaction (PCR) amplification, amplicon digestion, and microarray hybridization on a plastic support will be presented. In addition, this talk will also demonstrate the possibility to use new materials and fabrication processes to bridge the gap between the laboratory proof-of-concept Lab-On-Chip demonstrations and the industrial like fabrication production based on the use of low-cost thermoplastic elastomers.
&
Keynote Presentation
Paper/Plastic-based Nanomicrofluidics and Nanobiosensing Enhancement Opportunities Arben Merkoci, ICREA Research Professor & Group Leader, Catalan Institute of Nanoscience and Nanotechnology, Spain
Nanomaterials (NM) with electrical and optical properties are playing a key role in the design of cutting edge biosensing technologies. Electrocatalytic, plasmonic and quantic properties of NMs such as gold nanoparticles, quantum dots or graphene while operating in simple plastic or paper matrix in diagnostic and safety/security applications will be shown. The effect of the platform architecture and other chemical and physical parameters upon biosensing and actuation including nano/micromotors operations that may enhance detection will be discussed. The developed smart nanobiosystems are with interest for integration of diagnostic with therapies (nanotheranostics) or sensing and destruction/removal (sensoremoval) for health and environment industries. Examples related to protein (ex. neurodegenerative disease biomarkers), DNA (pathogen related) or cells (cancer cells) with interest for point of care (POC) applications will be shown. These are simple paper/plastic-based platforms that operate in either lateral flow or lab-on-a-chip formats.
It is well worth having a look at the conference agenda as their is 3 days of presentations. Some with better understanding of the bio world may come across something I have missed!!!
(20min delay)